We are live on ! Find out more
OC

Oarsman Capital Portfolio holdings

AUM $806M
1-Year Est. Return 19.96%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+19.96%
3 Year Est. Return
+61.37%
5 Year Est. Return
+74.92%
10 Year Est. Return
+242.94%
AUM
$237M
AUM Growth
+$17.9M
Cap. Flow
+$7.26M
Cap. Flow %
3.07%
Top 10 Hldgs %
21.82%
Holding
191
New
8
Increased
79
Reduced
68
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 10.56%
2 Consumer Discretionary 10.49%
3 Healthcare 10.29%
4 Industrials 10.23%
5 Technology 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHDG icon
101
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.19B
$540K 0.23%
17,609
+876
+5% +$26.3K
CAT icon
102
Caterpillar
CAT
$409B
$531K 0.22%
4,255
+350
+9% +$40.3K
EEM icon
103
iShares MSCI Emerging Markets ETF
EEM
$28.5B
$530K 0.22%
11,836
+725
+7% +$31.9K
VB icon
104
Vanguard Small-Cap ETF
VB
$79.5B
$525K 0.22%
3,712
-149
-4% -$20.3K
PX
105
DELISTED
Praxair Inc
PX
$521K 0.22%
3,728
-82
-2% -$10.9K
ULQ
106
DELISTED
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
$515K 0.22%
10,215
+300
+3% +$15.1K
WOOD icon
107
iShares Global Timber & Forestry ETF
WOOD
$258M
$514K 0.22%
7,697
-50
-0.6% -$3.17K
BIV icon
108
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$508K 0.21%
5,995
+130
+2% +$11K
GD icon
109
General Dynamics
GD
$105B
$505K 0.21%
2,455
-290
-11% -$58.1K
EFA icon
110
iShares MSCI EAFE ETF
EFA
$76.4B
$494K 0.21%
7,221
+600
+9% +$40.1K
DIS icon
111
Walt Disney
DIS
$165B
$492K 0.21%
4,987
+175
+4% +$18K
CHY
112
Calamos Convertible and High Income Fund
CHY
$1.03B
$483K 0.2%
40,612
+150
+0.4% +$1.77K
BSV icon
113
Vanguard Short-Term Bond ETF
BSV
$44.6B
$482K 0.2%
6,040
+250
+4% +$20K
DIA icon
114
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.3B
$481K 0.2%
2,150
DJP icon
115
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$819M
$481K 0.2%
20,684
-1,046
-5% -$24.1K
CEF icon
116
Sprott Physical Gold and Silver Trust
CEF
$7.43B
$478K 0.2%
37,720
-100
-0.3% -$1.26K
MCN
117
Madison Covered Call & Equity Strategy Fund
MCN
$117M
$474K 0.2%
60,432
-1,350
-2% -$10.6K
TGT icon
118
Target
TGT
$62.1B
$465K 0.2%
7,879
D icon
119
Dominion Energy
D
$62.5B
$461K 0.19%
5,987
BP icon
120
BP
BP
$113B
$456K 0.19%
13,168
-520
-4% -$16.5K
JWN
121
DELISTED
Nordstrom
JWN
$454K 0.19%
9,635
-1,200
-11% -$55.7K
PAYX icon
122
Paychex
PAYX
$40.4B
$453K 0.19%
7,560
-388
-5% -$22.2K
SCHR
123
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
$451K 0.19%
16,744
+492
+3% +$13.3K
AAXJ icon
124
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
$445K 0.19%
6,157
-110
-2% -$7.81K
SCHV
125
Schwab US Large-Cap Value ETF
SCHV
$15.8B
$441K 0.19%
25,521
+1,569
+7% +$26.6K

Similar funds

Oarsman Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Oarsman Capital held 191 positions worth $237M, up 8.2% from $219M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Oarsman Capital deployed $7.26M of net new capital in Q3 2017, opening 8 new positions and adding to 79 existing holdings. Its largest new stake was ProShares Short S&P500: 13,900 shares worth $1.79M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $970K trimmed.

  • Oarsman Capital's largest Q3 2017 buy was ProShares Short S&P500: 13,900 shares worth $1.79M.
  • Oarsman Capital added most to DuPont de Nemours in Q3 2017, an estimated $2.44M increase.
  • Oarsman Capital's biggest Q3 2017 reduction was Teva Pharmaceuticals, cutting an estimated $970K.
  • Oarsman Capital fully exited General Motors in Q3 2017, selling an estimated $1.31M.
  • Oarsman Capital's ten largest holdings make up 22% of its $237M portfolio in Q3 2017.
  • Oarsman Capital opened 8 new positions and closed 3 in Q3 2017.
  • Oarsman Capital's portfolio value rose 8.2% quarter-over-quarter to $237M.

Based on Oarsman Capital's 13F filing for Q3 2017, filed 13 Nov 2017.